Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0180
-0.0005 (-2.70%)
Jun 5, 2026, 4:10 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 16.24 million as of June 5, 2026. Its market cap has increased by 43.48% in one year.
Market Cap
16.24M
Enterprise Value
13.23M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 16.24M, a decrease of -92.58%. That is a compound annual growth rate of -34.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 16.24M | -44.31% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 48.61M |
| Nova Eye Medical | 33.47M |
| Control Bionics | 32.54M |
| Micro-X | 30.63M |
| CleanSpace Holdings | 27.62M |
| CurveBeam AI | 24.36M |
| CONNEQT Health | 17.38M |
| ImpediMed | 16.37M |